Skip to content

The ChillPref SF study

Children's preferences for TB medicines through drug suspension and flavouring agents (The ChilPref SF study) - A co-development and 'Swish-and-Spit' taste panel evaluation in children.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202410483015017
Enrollment
156
Registered
2024-10-10
Start date
2024-02-19
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

Component 1
Component 2
Component 3
All children will be on intervention arm with the same drugs fro tasting
No cobtrol

Sponsors

Stellenbosch University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: – Aged 3-17-years-old – Consent and assent, as relevant, provided

Exclusion criteria

Exclusion criteria: – Current TB disease (suspected or confirmed) – Current contact with an infectious TB patient – Undergoing dental care or treatment in the past 14 days – The use of mouthwash within 24 hours of the study visit – Smoking in the preceding 48 hours – Known drug allergies or history of hypersensitivity to antibiotics, or intolerance to or unwillingness to eat a culturally appropriate neutral “palate-cleanser” – Children with any current condition that influences taste or smell sensation (such as upper respiratory infection, mucositis, nasal congestion; self-reported sustained taste loss, including due to COVID-19, or use of medication that influences taste perception) – Inability to perform the ranking activity – Children who swallow by mistake or experience difficulty spitting out the solution

Design outcomes

Primary

MeasureTime frame
The ChilPref SF project has three components (each a swish-and-spit taste panel evaluation) that combine to provide best evidence on what suspending agent(s) and flavours to use in creating extemporaneous suspensions of key medications for RR-TB treatment for child patients

Secondary

MeasureTime frame
This is to contextualise the quantitative data in the words of participants. The researcher will ask the participants to “Tell me, in your own words, what did that taste like, whether they liked it or not and why?”

Countries

South Africa

Contacts

Public ContactTina Sachs

Project manager

tsachs@hotmail.com0027219389812

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026